Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Rambam Health Care Campus |
---|---|
Information provided by: | Rambam Health Care Campus |
ClinicalTrials.gov Identifier: | NCT00279474 |
The aim of the study is to evaluate the effect of cognitive behavior group intervention with cancer patients and their family members. Around 80 cancer patients and their family members will participate in group intervention and will be compared with 80 controls.
Condition | Intervention |
---|---|
Cancer |
Behavioral: cognitive-behavior groups |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Evaluation of the Effect of Cognitive Behavior Intervention on Psychological Distress of Cancer Patients and Their Family Members |
Estimated Enrollment: | 320 |
Study Start Date: | July 2004 |
Estimated Study Completion Date: | December 2005 |
The aim of the study is to evaluate the effect of cognitive behavior group intervention with cancer patients and their family members. Around 80 cancer patients and their family members will participate in group intervention and will be compared with 80 controls (randomized control study). Brief Symptom Inventory,Fatigue inventory, Mini Sleep Questionnaire and repression-sensitization questionnaire will be answered by the participants pre-, post-intervention and after four months.
Ages Eligible for Study: | 20 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Miri Cohen | 972 523 688623 | cohenm@research.haifa.ac.il |
Contact: Georgeta Fried | 972 4 853018 |
Israel | |
Rambam medical center, Oncology department | Recruiting |
Haifa, Israel | |
Contact: Miri Cohen, PhD 972 52 3688623 cohenm@research.haifa.ac.il |
Principal Investigator: | Miri Cohen, PhD | Rambam Health Care Campus |
Study ID Numbers: | 1951CTIL |
Study First Received: | January 17, 2006 |
Last Updated: | January 17, 2006 |
ClinicalTrials.gov Identifier: | NCT00279474 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
cancer patients family cognitive behavior distress |